Marta Guzmán
Impact in
Papers in
- Oncology 25
- HER2/EGFR in Cancer Research 12
- PARP inhibition in cancer therapy 8
- Cancer-related Molecular Pathways 3
- Peptidase Inhibition and Analysis 2
-
- Monoclonal and Polyclonal Antibodies Research 5
- Co-authors
- Maurizio Scaltriti (11 shared papers)Joaquin Arribas (9 shared papers)José Baselga (10 shared papers)Violeta Serra (9 shared papers)Federico Rojo (4 shared papers)Serena Di Cosimo (3 shared papers)José Baselga (5 shared papers)Pieter J.A. Eichhorn (5 shared papers)
- Journals
- Clinical Cancer Research (8 papers)Cancer Research (5 papers)Oncogene (3 papers)EMBO Molecular Medicine (2 papers)British Journal of Cancer (2 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Marta Guzmán
33 papers receiving 6.4k citations
Marta Guzmán's Hit Papers
Peers
Comparison fields: 5 of 110
- Oncology 3.8k
- Genetics 601
- Cancer Research 740
- Pulmonary and Respiratory Medicine 1.6k
- Radiology, Nuclear Medicine and Imaging 1.0k
Countries citing papers authored by Marta Guzmán
This map shows the geographic impact of Marta Guzmán's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Marta Guzmán with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Marta Guzmán more than expected).
Fields of papers citing papers by Marta Guzmán
This network shows the impact of papers produced by Marta Guzmán. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Marta Guzmán. The network helps show where Marta Guzmán may publish in the future.
Co-authors
The 25 scholars most cited alongside Marta Guzmán, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 35 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Expression of p95HER2, a Truncated Form of the HER2 Receptor, and Response to Anti-HER2 Therapies in Breast Cancer Hit paper breakdown → | 2007 | 730 |
| 2 | NVP-BEZ235, a Dual PI3K/mTOR Inhibitor, Prevents PI3K Signaling and Inhibits the Growth of Cancer Cells with Activating PI3K Mutations Hit paper breakdown → | 2008 | 676 |
| 3 | Early Adaptation and Acquired Resistance to CDK4/6 Inhibition in Estrogen Receptor–Positive Breast Cancer Hit paper breakdown → | 2016 | 607 |
| 4 | PI3K Inhibition Impairs BRCA1/2 Expression and Sensitizes BRCA-Proficient Triple-Negative Breast Cancer to PARP Inhibition Hit paper breakdown → | 2012 | 507 |
| 5 | 2011 | 466 | |
| 6 | 2008 | 412 | |
| 7 | 2008 | 376 | |
| 8 | 2015 | 359 | |
| 9 | 2018 | 348 | |
| 10 | 2011 | 290 | |
| 11 | 2004 | 247 | |
| 12 | ZD1839, a specific epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor, induces the formation of inactive EGFR/HER2 and EGFR/HER3 heterodimers and prevents heregulin signaling in HER2-overexpressing breast cancer cells. | 2003 | 223 |
| 13 | 2018 | 222 | |
| 14 | 2007 | 173 | |
| 15 | 2012 | 141 | |
| 16 | 2010 | 126 | |
| 17 | 2009 | 107 | |
| 18 | 2022 | 80 | |
| 19 | 2022 | 75 | |
| 20 | 2013 | 71 |
About Marta Guzmán
Marta Guzmán is a scholar working on Oncology, Radiology, Nuclear Medicine and Imaging, Genetics, Molecular Biology and Pulmonary and Respiratory Medicine, having authored 35 papers that have together received 6.6k indexed citations. Recurring topics across this work include HER2/EGFR in Cancer Research (12 papers), PARP inhibition in cancer therapy (8 papers), PI3K/AKT/mTOR signaling in cancer (6 papers), Monoclonal and Polyclonal Antibodies Research (5 papers), Cancer-related Molecular Pathways (3 papers), Advanced Breast Cancer Therapies (3 papers), Chronic Lymphocytic Leukemia Research (3 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Oncology (3.8k citations), Genetics (601 citations), Cancer Research (740 citations), Pulmonary and Respiratory Medicine (1.6k citations) and Radiology, Nuclear Medicine and Imaging (1.0k citations). Marta Guzmán has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include Maurizio Scaltriti, Joaquin Arribas, José Baselga, Violeta Serra, Federico Rojo, Serena Di Cosimo, José Baselga, Pieter J.A. Eichhorn, Santiago Ramón y Cajal and Javier Cortés. Their work appears in journals such as Clinical Cancer Research, Cancer Research, Oncogene, EMBO Molecular Medicine and British Journal of Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.